Modeling prostate cancer response to continuous versus intermittent androgen ablation therapy

From MaRDI portal
Publication:378944

DOI10.3934/dcdsb.2013.18.945zbMath1277.92013OpenAlexW2327525276MaRDI QIDQ378944

Avner Friedman, Harsh Vardhan Jain

Publication date: 12 November 2013

Published in: Discrete and Continuous Dynamical Systems. Series B (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.3934/dcdsb.2013.18.945




Related Items (17)

A new protocol for intermittent androgen suppression therapy of prostate cancer with unstable saddle-point dynamicsDynamics and implications of models for intermittent androgen suppression therapyPredictability and identifiability assessment of models for prostate cancer under androgen suppression therapyComparison between mathematical models of intermittent androgen suppression for prostate cancerModeling the effects of chemotherapeutic dose response on a stochastic tumor-immune model of prostate cancer with androgen deprivation therapyOptimization therapy by coupling intermittent androgen suppression with impulsive chemotherapy for a prostate cancer modelSelection of prostate cancer therapy strategy under early androgen suppression treatmentStability analysis on a hybrid PDE–ODE system describing intermittent hormonal therapy of prostate cancerStationary distribution and persistence of a stochastic mathematical model for prostate cancer with pulsed therapyBifurcation Analysis of Mathematical Model of Prostate Cancer with ImmunotherapyAnalysis of mathematical model of prostate cancer with androgen deprivation therapyAndrogen driven evolutionary population dynamics in prostate cancer growthGlobal dynamics of a model of joint hormone treatment with dendritic cell vaccine for prostate cancerAbility of intermittent androgen suppression to selectively create a non-trivial periodic orbit for a type of prostate cancer patientsMathematics + Cancer: An Undergraduate "Bridge" Course in Applied MathematicsDynamical Aspects of a Hybrid System Describing Intermittent Androgen Suppression Therapy of Prostate CancerThe Impact of Fractional Differentiation in Terms of Fitting for a Prostate Cancer Model Under Intermittent Androgen Suppression Therapy




This page was built for publication: Modeling prostate cancer response to continuous versus intermittent androgen ablation therapy